Cognitive behavioral therapy (CBT) in depression

Article written and reviewed by Dr Luca Moretti

Cognitive behavioral therapy, commonly referred to by the acronym CBT, is one of the most extensively studied psychotherapies for major depressive disorder. It is not a single technique, but a family of interventions characterized by explicit case formulation, collaboration between patient and therapist, verifiable goals and systematic use of cognitive and behavioral strategies. In depression, CBT aims to interrupt processes that maintain the episode, including reduced activity, avoidance, loss of reinforcement, negative automatic thoughts, rigid beliefs and interpretive patterns that amplify helplessness and hopelessness. The intervention is directed both toward improvement of the current episode and toward acquisition of skills that can be used after therapy ends.

Modern CBT derives largely from Beck's cognitive therapy and from the behavioral tradition. For this reason, the distinction between “cognitive therapy” and “CBT” should not be turned into an artificial separation between two treatments with no overlap. Many depression protocols combine behavioral activation, problem solving, behavioral experiments and work on thoughts and beliefs. The relative contribution of each element is adapted to the formulation of the individual case.

Cognitive behavioral model of depression

In the cognitive model, experiences are interpreted through structures of meaning developed over the course of life. During a depressive episode, negative automatic thoughts concerning the self, the world and the future may become particularly accessible. The so called Beck cognitive triad describes this tendency, but it should not be understood as a biomarker or as a single necessary cause of depression. Cognitive content interacts with biological vulnerabilities, life events, relationships, sleep, behavior, physical health and other determinants of the disorder.

A person who interprets a mistake as proof of global incapacity may reduce effort, avoid evaluative situations and withdraw from previously meaningful activities. Withdrawal reduces opportunities for gratification, mastery and correction of negative expectations. Reduced activity may therefore confirm the belief of no longer being capable and intensify anhedonia, guilt and helplessness. CBT describes these cycles as maintenance processes that can be modified, not as a complete explanation of the etiology of depressive disorder.

The behavioral component also considers the function of avoidance. Staying in bed, postponing tasks, interrupting social contact or abandoning demanding activities may temporarily reduce fatigue, anxiety or exposure to possible failure. This immediate relief reinforces avoidance, while over the medium term it increases isolation, inactivity and loss of corrective experiences. Analyzing this sequence makes it possible to design interventions that gradually modify the relationship between behavior and context.

At the cognitive level, distortions or biases such as overgeneralization, selective attention to negative information, dichotomous thinking, inferences insufficiently supported by data, and global and stable attributions for failures are also considered. Therapy does not assume that every pessimistic thought is false. The goal is to assess its accuracy, usefulness and flexibility, distinguishing among real problems, predictions, interpretations and excessively rigid personal rules. This makes cognitive work different from simply replacing negative thoughts with positive statements.

The model is reciprocal, not linear. A behavioral change can alter opportunities for reinforcement and beliefs, while a new interpretation can increase willingness to act. Biological factors, sleep, medical illnesses, medications and social conditions can also enter the same cycle. For this reason, CBT does not claim that depression is “caused by negative thoughts”: it uses cognitive and behavioral processes as modifiable targets within a broader formulation.

Assessment, case formulation and goals

CBT begins with a comprehensive clinical assessment, not with immediate application of a technical worksheet. In addition to diagnosis and episode severity, suicide risk, a history of mania or hypomania, psychotic symptoms, substance use, comorbidities, medical conditions, current medications and previous treatments should be assessed. These elements determine whether psychotherapy can be delivered in an outpatient setting as the main intervention or should be incorporated into more intensive management.

Cognitive behavioral formulation organizes information into an individualized model. Triggering situations, thoughts, emotions, physical sensations, behaviors and consequences are reconstructed, together with more stable beliefs that may make certain situations particularly meaningful. A useful formulation should explain current problems and identify concrete points for intervention. It is not an immutable theoretical label: it is updated when new clinical data contradict the initial hypotheses.

Goals are formulated in observable and clinically relevant terms. Reducing a score on a scale can be useful for monitoring response, but does not replace goals such as returning to work, restoring regular sleep, reconnecting with significant people, reducing time spent ruminating or approaching avoided activities. Shared definition of goals makes it possible to determine whether therapy is improving functioning in addition to symptoms.

Monitoring may include validated scales such as the PHQ-9, BDI-II or other appropriate measures, activity records and assessments of functioning. Scores should be interpreted in clinical context and do not by themselves establish diagnosis, remission or indication for a specific therapy. An insufficient response requires review of the formulation, adherence, treatment dose, comorbidities and the need for pharmacotherapy or a different level of care.

Goals are translated into observable indicators and ordered by priority. Reducing a depression scale score is important but not sufficient: return to work, sleep regularity, self care, relationships and meaningful activities can also be monitored. The formulation should also be sensitive to cultural and social context because beliefs and behaviors have different meanings according to norms, roles, discrimination and available resources. This helps avoid pathologizing understandable reactions to real circumstances.

Behavioral and cognitive techniques

In the early phases, behavioral activation is often used, especially when depression has produced marked inertia and withdrawal. Patient and therapist observe the relationship between activity and mood, identify patterns of avoidance and plan gradual actions with personal value or the potential to generate mastery. The goal is not to force the person to be active or generically prescribe physical exercise, but to generate new experiences that counter the cycle between passivity and worsening mood.

Work on automatic thoughts uses records of situations, identification of interpretations and evaluation of evidence for and against them. Socratic dialogue consists of questions that encourage independent examination rather than a dispute in which the therapist tries to convince the patient that they are “thinking incorrectly”. Whenever possible, hypotheses are tested through behavioral experiments in the real world. A patient convinced that any request for help will lead to rejection can formulate a specific prediction, try a behavior and compare the outcome with the initial expectation.

Treatment can progress from situational cognitions to intermediate beliefs, such as conditional rules and rigid standards, and to more general schemas. Perfectionism, need for approval or interpreting an error as personal failure are not modified by a single verbal refutation. CBT uses repeated experiments, continued data collection and development of more flexible rules that can be tested in everyday behavior.

Additional tools include problem solving, skills training when indicated, planning for sleep and routines, strategies for rumination, exposure to avoided situations and work on self compassion or self criticism within protocols that integrate these components. Not every technique belongs to every protocol and they should not be applied as a standard list. The choice depends on the mechanisms identified in the formulation.

Technique selection follows an experimental logic. If the dominant problem is withdrawal, activation may precede more elaborate cognitive work; if the person avoids situations because of specific predictions, a behavioral experiment may provide more useful information than an abstract discussion. Problem solving techniques, exposure or skills training are integrated when consistent with the formulation and any comorbidities, without turning the session into an uncoordinated collection of exercises.

Session structure and treatment adaptation

CBT is generally structured, but structure does not mean rigidity. Sessions typically include a clinical update, agenda setting, review of work completed between meetings, exploration of priority problems, application of techniques and agreement on next steps. This organization makes the pathway transparent and encourages the patient's active participation.

Between session exercises extend treatment into real life. They may consist of monitoring, scheduled activities, readings, experiments or application of agreed strategies. They should be specific and realistic enough to be completed even when energy and motivation are reduced. Noncompletion should not be treated as disobedience, but analyzed to understand obstacles, expectations, organization and level of difficulty.

There is no universal number of sessions that applies to all CBT for depression. Classical protocols are often time limited, but duration varies with severity, chronicity, comorbidities, response and setting. Assigning CBT a rigid duration of 12 to 20 sessions is therefore an oversimplification. Therapy should have sufficient intensity to obtain measurable benefit and a planned ending, with the possibility of extension when clinically justified.

Adaptations are possible for older adults, people with chronic illnesses, mild cognitive deficits, different literacy levels, different cultural contexts or digital delivery. Adaptations may involve language, pace, written supports, caregiver involvement when appropriate and greater emphasis on behavioral interventions. They should preserve the active principles of treatment and not turn CBT into unstructured counseling.

Structure should not become rigidity. Agenda, review, central work and summary are intended to make treatment transparent, but they can be adapted when clinically urgent events arise. Written materials should be modified in the presence of low literacy, visual difficulties or cognitive deficits; sessions and assignments may be shorter when fatigue or medical illness limits tolerance. Fidelity to CBT concerns its principles and formulation, not identical reproduction of a session outline.

Clinical efficacy and position in guidelines

CBT is supported by hundreds of trials and numerous meta analyses. The broadest syntheses confirm benefit compared with control conditions and average efficacy comparable to that of other structured psychotherapies. Effect sizes are smaller when higher quality studies and active controls are considered, an important point for avoiding an excessively optimistic representation.

Classic studies in moderate or severe depression have shown that cognitive therapy delivered by experienced therapists can achieve results comparable to pharmacotherapy during the acute phase in specific research populations. These findings do not demonstrate that every patient with severe depression can be safely treated with CBT alone. Suicide risk, psychosis, catatonia, severe nutritional compromise or the need for a very rapid response may require more intensive medical interventions.

NICE, CANMAT, VA/DoD and APA include CBT among evidence based options for depression. Recommendations vary by severity, format and population, but converge on the need to individualize treatment selection. It is therefore inaccurate to describe CBT as obligatorily combined with medication in every more severe presentation or, conversely, as a therapy reserved exclusively for mild depression.

The direct comparison with behavioral activation in the COBRA trial showed noninferiority of BA to CBT in the study context and lower intervention costs. This finding supports the availability of multiple effective psychotherapies, but does not prove that BA is superior or make CBT redundant. The choice may depend on clinical profile, acceptability and service resources.

The breadth of the literature allows individual, group, guided and digital CBT to be studied, but these formats should not automatically be considered equivalent. Therapist support, sample severity and clinical complexity influence outcomes. Guidelines therefore tend to differentiate intensity and format according to needs, and the existence of effective digital CBT in a trial does not imply that an unsupervised app is appropriate for severe depression.

Medication, continuation phase and relapse prevention

Psychotherapy and antidepressants can be used as alternatives or in combination. Meta analyses indicate that combined treatment can offer an advantage over pharmacotherapy alone in many patients with depression, while comparisons between psychotherapy and medication alone often show modest average differences. The decision should consider preferences, severity, response history, adverse effects, comorbidities and the need for long term prevention.

A clinically important feature of cognitive therapy and CBT is the possibility of a lasting effect after the acute phase has ended. In trials by Hollon and colleagues, patients who had responded to cognitive therapy showed protection against relapse after treatment ended, comparable to continuation pharmacotherapy within that specific study design. This is not a guarantee of immunity from recurrence: recurrent depression, residual symptoms and risk factors may require additional treatment.

Relapse prevention is prepared before treatment ends. Patient and therapist reconstruct early warning signs, high risk situations, strategies that have proved effective and ways to access new care rapidly. It may be useful to produce a concise document containing the personal formulation, acquired tools and a plan for responding to persistent changes in sleep, activity, rumination or mood.

For recurrent depression, mindfulness based cognitive therapy can also be considered because it has a specific evidence base for relapse prevention. MBCT should not be confused with simple meditation practice and is a protocol distinct from standard acute phase CBT.

When CBT and antidepressants are combined, monitoring should distinguish response, remission and residual symptoms and establish which component of the plan will continue after the acute phase. Pharmacological discontinuation, when appropriate, requires tapering agreed with the prescriber and attention to discontinuation symptoms, which may be confused with relapse. CBT can provide prevention tools, but it does not make a history of recurrent or severe episodes clinically irrelevant.

Limitations, possible difficulties and safety

CBT does not work for every patient and there is no personality profile that guarantees efficacy. Low initial motivation is common in depression and is not an automatic contraindication; gradual activation often helps create the conditions for greater engagement. More relevant factors are the ability to participate with sufficient continuity, the therapist's capacity to adapt treatment and the absence of unmanaged urgent clinical needs.

Therapy can produce transient discomfort when the patient approaches avoided activities, examines painful beliefs or tries new behaviors. Persistent worsening, increased suicide risk or emergence of manic or psychotic symptoms require immediate reassessment and should not be generically attributed to the idea that “therapy is working”.

A practical limitation is variability in therapist competence. The evidence concerns protocols delivered with adequate training and supervision; using the label CBT does not guarantee that a treatment reproduces the interventions that were studied. Fidelity to the model should coexist with individualized formulation, avoiding both a mechanical sequence of worksheets and therapy without structure.

Overall, CBT remains one of the best supported options for depression. Its value lies in combining a testable model, behavioral and cognitive strategies, response monitoring and transfer of skills into everyday life. The best outcome is achieved when it is selected for an appropriate patient, delivered by competent professionals and integrated with other levels of care required by clinical severity.

CBT can also produce transient difficulties: approaching avoided activities, recording thoughts or carrying out exposures can temporarily increase distress. This does not demonstrate that treatment is failing, but it requires consent, titration and monitoring. Persistent worsening, however, should prompt reassessment of diagnosis, therapeutic alliance, intensity and protocol appropriateness. Responsibility should not be attributed to the patient as “lack of motivation” without analyzing the actual obstacles.

Bibliography
1. National Institute for Health and Care Excellence. Depression in adults: treatment and management. NICE guideline NG222. 2022; last reviewed 2026.
2. Lam RW et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults. Canadian Journal of Psychiatry. 69(9), 2024, 641-687.
3. Department of Veterans Affairs, Department of Defense. VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder. Version 4.0. Washington, DC, 2022.
4. American Psychological Association. Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts. Washington, DC: American Psychological Association, 2019.
5. Cuijpers P et al. Psychotherapies for depression: a network meta-analysis covering efficacy, acceptability and long-term outcomes of all main treatment types. World Psychiatry. 20(2), 2021, 283-293.
6. Cuijpers P et al. Cognitive behavior therapy vs. control conditions, other psychotherapies, pharmacotherapies and combined treatment for depression: a comprehensive meta-analysis including 409 trials with 52,702 patients. World Psychiatry. 22(1), 2023, 105-115.
7. Cuijpers P et al. Psychologic Treatment of Depression Compared With Pharmacotherapy and Combined Treatment in Primary Care: A Network Meta-Analysis. Annals of Family Medicine. 19(3), 2021, 262-270.
8. Cuijpers P et al. Adding psychotherapy to antidepressant medication in depression and anxiety disorders: a meta-analysis. World Psychiatry. 13(1), 2014, 56-67.
9. Barth J et al. Comparative efficacy of seven psychotherapeutic interventions for patients with depression: a network meta-analysis. PLoS Medicine. 10(5), 2013, e1001454.
10. Beck AT et al. Cognitive Therapy of Depression. New York: Guilford Press, 1979.
11. Beck JS. Cognitive Behavior Therapy: Basics and Beyond. 3rd ed. New York: Guilford Press, 2020.
12. DeRubeis RJ et al. Cognitive therapy vs medications in the treatment of moderate to severe depression. Archives of General Psychiatry. 62(4), 2005, 409-416.
13. Hollon SD et al. Prevention of relapse following cognitive therapy vs medications in moderate to severe depression. Archives of General Psychiatry. 62(4), 2005, 417-422.
14. Dimidjian S et al. Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression. Journal of Consulting and Clinical Psychology. 74(4), 2006, 658-670.
15. Richards DA et al. Cost and Outcome of Behavioural Activation versus Cognitive Behavioural Therapy for Depression (COBRA): a randomised, controlled, non-inferiority trial. Lancet. 388(10047), 2016, 871-880.